Clinicopathologic correlates of common cancer pain syndromes

Research output: Contribution to journalArticle

Abstract

The development of a treatment strategy for the management of cancer pain is based on a patient evaluation that elucidates the pain syndrome and predominant pathophysiologic mechanism responsible for the pain. Coupled with evaluation of pain intensity, and the extent of functional and emotional disturbance, this assessment facilitates appropriate selection of primary and analgesic therapies to address the problem of patient distress.

Original languageEnglish
Pages (from-to)57-78
Number of pages22
JournalHematology/Oncology Clinics of North America
Volume10
Issue number1
DOIs
Publication statusPublished - 1996

Fingerprint

Pain
Affective Symptoms
Analgesics
Therapeutics
Cancer Pain

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

Clinicopathologic correlates of common cancer pain syndromes. / Caraceni, A.

In: Hematology/Oncology Clinics of North America, Vol. 10, No. 1, 1996, p. 57-78.

Research output: Contribution to journalArticle

@article{8d042fbe8c03458b95c3194f8e155647,
title = "Clinicopathologic correlates of common cancer pain syndromes",
abstract = "The development of a treatment strategy for the management of cancer pain is based on a patient evaluation that elucidates the pain syndrome and predominant pathophysiologic mechanism responsible for the pain. Coupled with evaluation of pain intensity, and the extent of functional and emotional disturbance, this assessment facilitates appropriate selection of primary and analgesic therapies to address the problem of patient distress.",
author = "A. Caraceni",
year = "1996",
doi = "10.1016/S0889-8588(05)70327-0",
language = "English",
volume = "10",
pages = "57--78",
journal = "Hematology/Oncology Clinics of North America",
issn = "0889-8588",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Clinicopathologic correlates of common cancer pain syndromes

AU - Caraceni, A.

PY - 1996

Y1 - 1996

N2 - The development of a treatment strategy for the management of cancer pain is based on a patient evaluation that elucidates the pain syndrome and predominant pathophysiologic mechanism responsible for the pain. Coupled with evaluation of pain intensity, and the extent of functional and emotional disturbance, this assessment facilitates appropriate selection of primary and analgesic therapies to address the problem of patient distress.

AB - The development of a treatment strategy for the management of cancer pain is based on a patient evaluation that elucidates the pain syndrome and predominant pathophysiologic mechanism responsible for the pain. Coupled with evaluation of pain intensity, and the extent of functional and emotional disturbance, this assessment facilitates appropriate selection of primary and analgesic therapies to address the problem of patient distress.

UR - http://www.scopus.com/inward/record.url?scp=0030043149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030043149&partnerID=8YFLogxK

U2 - 10.1016/S0889-8588(05)70327-0

DO - 10.1016/S0889-8588(05)70327-0

M3 - Article

C2 - 8821560

AN - SCOPUS:0030043149

VL - 10

SP - 57

EP - 78

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

SN - 0889-8588

IS - 1

ER -